Related Experiment Video
Updated: Aug 6, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Insulin therapy and carbohydrate counting
Gaia Chiesa1, Maria Antonietta Piscopo, Andrea Rigamonti
1Department of Pediatrics, Endocrine Unit, Scientific Institute Hospital San Raffaele, Vita-Salute University, Milan, Italy.
Acta Bio-Medica : Atenei Parmensis
|August 19, 2006
Summary
Consistent carbohydrate counting in Type 1 diabetes management improves blood glucose control. This approach allows for greater dietary flexibility while focusing on carbohydrate intake to manage glycemic responses.
Area of Science:
- Endocrinology
- Nutrition Science
- Metabolic Disorders
Background:
- Nutritional management is crucial for diabetes care, particularly Type 1 diabetes.
- Carbohydrate intake significantly impacts postprandial glycemic response and insulin needs.
- Consistency in carbohydrate quantity and source aids blood glucose control.
Purpose of the Study:
- To review existing literature on the importance of carbohydrate counting in Type 1 diabetes.
- To evaluate how carbohydrate counting impacts achieving treatment goals.
- To assess the role of carbohydrate counting in enhancing dietary flexibility.
Main Methods:
- Literature review of published data on carbohydrate counting methods.
- Analysis of studies correlating carbohydrate intake with glycemic control in Type 1 diabetes.
- Examination of various carbohydrate counting strategies (grams, glycemic index, etc.).
Main Results:
- Carbohydrate counting is a key meal planning strategy for Type 1 diabetes.
- Accurate carbohydrate counting helps manage postprandial glucose levels.
- Methods like grams and carbohydrate/insulin ratio are commonly used.
Conclusions:
- Carbohydrate counting is significant for meeting glycemic outcome goals in Type 1 diabetes.
- This approach offers flexibility in food choices for patients.
- Effective nutritional management through carbohydrate counting is vital for diabetes care.
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...